Guardian Pharmacy Earnings: Margin Expansion And Raised Guidance Signal Operational Strength

Guardian Pharmacy Services (GRDN) reported strong Q4 2025 earnings, exceeding EPS estimates and showing significant margin expansion and robust EBITDA growth. The company raised its full-year 2026 adjusted EBITDA guidance, reflecting operational strength, successful acquisition integration, and improved vaccine profitability. Despite a muted market reaction due to maintained revenue guidance, management emphasized disciplined execution and scalable operations for continued growth.